APPLIED IMMUNE BEGINS PHASE IIApplied Immune Sciences Inc. (NASDAQ:AISX) of South SanFrancisco, Calif., announced that it has begun Phase II trials onits cell therapy for AIDS in 20 patients at the University ofCalifornia, San Francisco. Celltech Group plc of Slough, England,announced that it has spun off its contract manufacturingbusiness as an independent, wholly owned subsidiary, CelltechBiologics plc.

(c) 1997 American Health Consultants. All rights reserved.